Regulations.gov document
Attachment 4 - "Labeling Brand Antivert and InvaGen's Meclizine Hydrochloride Chewable…
Supporting & Related Material · FDA-2011-P-0047 · posted Feb 8, 2011
Key facts
| Document ID | FDA-2011-P-0047-0005 |
|---|---|
| Title | Attachment 4 - "Labeling Brand Antivert and InvaGen's Meclizine Hydrochloride Chewable Tablets...." - [InvaGen Pharmaceuticals, Inc. - Citizen Petition] |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2011-P-0047 |
| Posted | Feb 8, 2011 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: